Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
346
NCT00251849
PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 2005
Completion: Dec 31, 2007
NCT00385385
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Phase: Phase 2
Start: Oct 31, 2006
Completion: Sep 30, 2008